ArticleJournal of pharmacokinetics and pharmacodynamics2025
Defining preclinical efficacy with the DNAPK inhibitor AZD7648 in combination with olaparib: a minimal systems pharmacokinetic-pharmacodynamic model.
Joost DeJongh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.